regionbassenormandie

Fédération des registres de cancers de Basse-Normandie

inca
CHUcaen
invs
baclesse
CHPC

université de caen


Contacter le webmaster
Copyright© 2008| Date de mise à jour:

Publications

Clin B, Morlais F, Launoy G, Guizard AV, Dubois B, Bouvier V, Desoubeaux N, Marquignon MF, Raffaelli C, Paris C, Galateau-Salle F, Guittet L, Letourneux M. Cancer incidence within a cohort occupationally exposed to asbestos: a study of dose-response relationships. Occup Environ Med. 2011 Mar 15. [Epub ahead of print]

Jean D, Thomas E, Manié E, Renier A, de Reynies A, Lecomte C, Andujar P, Fleury-Feith J, Galateau-Sallé F, Giovannini M, Zucman-Rossi J, Stern MH, Jaurand MC. Syntenic relationships between genomic profiles of fiber-induced murine and human malignant mesothelioma. Am J Pathol. 2011;178:881-94.

Rolland P, Gramond C, Lacourt A, Astoul P, Chamming's S, Ducamp S, Frenay C, Galateau-Salle F, Ilg AG, Imbernon E, Le Stang N, Pairon JC, Goldberg M, Brochard P; PNSM Study Group. Occupations and industries in France at high risk for pleural mesothelioma: A population-based case-control study (1998-2002). Am J Ind Med. 2010;53:1207-19.

Lacourt A, Rolland P, Gramond C, Astoul P, Chamming's S, Ducamp S, Frenay C, Galateau-Sallé F, Gilg Soit Ilg A, Imbernon E, Le Stang N, Pairon JC, Goldberg M, Iwatsubo Y, Salmi LR, Brochard P. Attributable risk in men in two French case-control studies on mesothelioma and asbestos. Eur J Epidemiol. 2010;25:799-806.

Le Stang N, Belot A, Gilg Soit Ilg A, Rolland P, Astoul P, Bara S, Brochard P, Danzon A, Delafosse P, Grosclaude P, Guizard AV, Imbernon E, Lapôtre-Ledoux B, Ligier K, Molinié F, Pairon JC, Sauleau EA, Trétarre B, Velten M, Bossard N, Goldberg M, Launoy G, Galateau-Sallé F. Evolution of pleural cancers and malignant pleural mesothelioma incidence in France between 1980 and 2005. Int J Cancer. 2010;126:232-8.

Scherpereel A, Astoul P, Baas P, Berghmans T, Clayson H, de Vuyst P, Dienemann H, Galateau-Salle F, Hennequin C, Hillerdal G, Le Péchoux C, Mutti L, Pairon JC, Stahel R, van Houtte P, van Meerbeeck J, Waller D, Weder W. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Zhongguo Fei Ai Za Zhi. 2010;13:C23-45.

Scherpereel A, Astoul P, Baas P, Berghmans T, Clayson H, de Vuyst P, Dienemann H, Galateau-Salle F, Hennequin C, Hillerdal G, Le Péchoux C, Mutti L, Pairon JC, Stahel R, van Houtte P, van Meerbeeck J, Waller D, Weder W; European Respiratory Society/European Society of Thoracic Surgeons Task Force. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J. 2010;35:479-95.

Bellocq JP, Arnould L, Chenard MP, Ettore F, Galateau-Sallé F, Michenet P, Michiels JF, Molina T, Penault-Llorca F. Indications de l’immunohistochimie dans le mésothéliome. Ann Pathol. 2009;29 Spec No 1:S96-7.

Husain AN, Colby TV, Ordóñez NG, Krausz T, Borczuk A, Cagle PT, Chirieac LR, Churg A, Galateau-Salle F, Gibbs AR, Gown AM, Hammar SP, Litzky LA, Roggli VL, Travis WD, Wick MR. Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med. 2009;133:1317-31.

Vlastos F, Hillas G, Vidal P, Lacomme S, Galateau-Sallé F, Vollmer E, Guzman-Costabel J, Vignaud JM, Martinet N. Survey and Biological Insights of Pemetrexed-Related Therapeutic Improvement in Mesothelioma: The Nancy Centre of Biological Resources' Mesothelioma Cohort. J Thorac Oncol. 2009 Jun 19.

Daubriac J, Fleury-Feith J, Kheuang L, Galipon J, Saint-Albin A, Renier A, Giovannini M, Galateau-Sallé F, Jaurand MC. Malignant pleural mesothelioma cells resist anoikis as quiescent pluricellular aggregates. Cell Death Differ. 2009;16:1146-55.

Clin B, Morlais F, Dubois B, Guizard AV, Desoubeaux N, Marquignon MF, Raffaelli C, Paris C, Galateau-Salle F, Launoy G, Letourneux M. Occupational asbestos exposure and digestive cancers - a cohort study. Aliment Pharmacol Ther. 2009;30:364-74.

Belot A, Grosclaude P, Bossard N, Jougla E, Benhamou E, Delafosse P, Guizard AV, Molinié F, Danzon A, Bara S, Bouvier AM, Trétarre B, Binder-Foucard F, Colonna M, Daubisse L, Hédelin G, Launoy G, Le Stang N, Maynadié M, Monnereau A, Troussard X, Faivre J, Collignon A, Janoray I, Arveux P, Buemi A, Raverdy N, Schvartz C, Bovet M, Chérié-Challine L, Estève J, Remontet L, Velten M. Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique. 2008;56:159-75.

Kothmaier H, Quehenberger F, Halbwedl I, Morbini P, Demirag F, Zeren H, Comin CE,Murer B, Cagle PT, Attanoos R, Gibbs AR, Galateau-Salle F, Popper HH. EGFR and PDGFR differentially promote growth in malignant epithelioid mesothelioma of short and long term survivors. Thorax. 2008;63:345-51.

Letourneux M, Paris C, Pommier De Santi P, Clin B, Marquignon MF, Galateau-Sallé F. Benign asbestos-related pleuropulmonary diseases. Rev Mal Respir. 2007;24:1299-313.

Gilg soit Ilg A, Chamming’s S, Rolland P, Ducamp S, Brochard P, Galateau-Sallé F, Pairon JC, Astoul P, de Quillac A, Frenay C, Goldberg M, Imbernon E. Programme national de surveillance du mésotheliome (PNSM) : principaux résultats, France, 1998-2004. Bull Epidémio Hebdo 2007;41-42 :350-54.

Vignaud JM, Sabourin JC, Barnoud AL, Copin MC, Devouassoux-Shisheborn M, Galateau-Salle F, Moreno-Swirc S, Noël JC. Pathology of pleural and peritoneal serosa. Ann Pathol. 2007;27:195.

Weinbreck N, Vignaud JM, Begueret H, Burke L, Benhattar J, Guillou L, Capron F, Galateau-Salle F. SYT-SSX fusion is absent in sarcomatoid mesothelioma allowing its distinction from synovial sarcoma of the pleura. Mod Pathol. 2007;20:617-21.

Galateau-Sallé F, Attanoos R, Gibbs AR, Burke L, Astoul P, Rolland P, Ilg AG, Pairon JC, Brochard P, Begueret H, Vignaud JM, Kerr K, Launoy G, Imbernon E, Goldberg M. Lymphohistiocytoid variant of malignant mesothelioma of the pleura: a series of 22 cases. Am J Surg Pathol. 2007;31:711-6.

Le Neindre B, Bouvier V, Galateau-Sallé F, de Quillacq A, Launoy G, Letourneux M. Compensation of malignant mesothelioma as an occupational disease in Lower Normandy, from 1995 to 2002. Rev Epidemiol Sante Publique. 2007;55123-31.

Geoffroy-Perez B, Imbernon E, Gilg Soit Ilg A, Goldberg. M. Confrontation des données du Programme national de surveillance du mésothéliome (PNSM) et du Programme de médicalisation du système d'information (PMSI). Rev Epid Santé Publ, 2006; 54:475-83.

Pairon JC, Fournier M, Astoul P, Galateau-Sallé F, Brochard P. Medical-social aspects of pleural mesothelioma. Rev Mal Respir. 2006; 23:11S101-4.

Galateau-Sallé F, Copin MC, Delajartre AY, Vignaud JM, Astoul P, Pairon JC, Le Pimpec-Barthes F, Brochard P. Which criteria for the anatomopathologic diagnosis of malignant pleural mesothelioma? Rev Mal Respir. 2006;23:11S37-44.

Pairon JC, Jaurand MC, Laurent F, Salmi R, Astoul P, Galateau-Sallé F, Brochard P. How to assess asbestos exposure and identify a population at risk? Rev Mal Respir. 2006; 23:11S9-27.

Andino L, Cagle PT, Murer B, Lu L, Popper HH, Galateau-Salle F, Sienko AE, Barrios R, Zander DS. Pleuropulmonary desmoid tumors: immunohistochemical comparison with solitary fibrous tumors and assessment of beta-catenin and cyclin D1 expression. Arch Pathol Lab Med. 2006;130:1503-9.

Goldberg M, Imbernon E, Rolland P, Gilg Soit Ilg A, Savès M, de Quillacq A, Frenay C, Chamming's S, Arveux P, Boutin C, Launoy G, Pairon JC, Astoul P, Galateau-Sallé F, Brochard P. The French National Mesothelioma Surveillance Program. Occup Environ Med. 2006; 63:390-5.

Galateau-Salle F, Brambilla E, Cagle P, Churg A, Colby T, Hammar S, Hasleton P, Gibbs AR, Kouki I, Roggli V, Travis WD, Vignaud JM, Pathology of Malignant mesothelioma; an update of the International Mesothelioma Panel in: Galateau –Sallé F, London, Springer Verlag 2006.

Galateau-Sallé F, Vignaud JM, Burke L, Gibbs A, Brambilla R, Attanoos R, Goldberg M, Launoy G. Well- Differentiated Mesothelioma of the Pleura. Am J Surg Pathol. 2004;28:534-40.

Rihn BH, Mohr S, McDowell SA, Binet S, Loubinoux J, Galateau F, Keith G, Leikauf GD. Differential gene expression in mesothelioma. FEBS Lett. 2000;480:95-100.

Le Stang N, Molinié F, Galateau-Sallé F, Launoy G. Commentaires de la fiche plèvre. Mise en ligne en février 2008 sur le site de InVS. http://www.invs.sante.fr/surveillance/cancers/estimations_cancers/default.htm

Galateau-Sallé F, Cagle P. Non malignant versus malignant proliferations on pleural biopsy. In Diagnostic Pulmonary Pathology . Eds P.T.Cagle. Marcel Dekker New York. 2nd version. 2007.

Galateau-Sallé F, Vignaud.JM. Diffuse malignant mesothelioma. Genetic pathways, mechanisms of oncogenesis and other agents that cause mesotheliomas. Molecular Pathology of Lung Diseases to be edited by Philip Cagle, Dani S. Zander, Jaishree Jagirdar, Roberto Barrios, Abida Haque and Helmut Popper Springer Verlag. New York, 2007.

Galateau-Sallé F, Astoul P, Chammings' S, pochard P, Gilg Soit Ilg A, Launoy G, Pairon JC, Rolland P, Goldberg M, Imbernon E. Anatomie pathologie du mésothéliome pleural. In : Astoul P (Ed) Le mésothéliome pleural. Paris, Elsevier, 2005 : 89-107